Data Snapshots are informative descriptions and quick analyses that dig into CSET’s unique data resources. This short series explores how government procurement data can shed light on federal technological interest and utilization. It analyzes contract metadata, provided in a collaborative project with Govini, to track key emerging technologies through the federal procurement process.

The choice of method for surfacing AI-relevant publications impacts the ultimate research findings. This report provides a quantitative analysis of various methods available to researchers for identifying AI-relevant research within CSET’s merged corpus, and showcases the research implications of each method.

Data Snapshots are informative descriptions and quick analyses that dig into CSET’s unique data resources. This short series explores how government procurement data can shed light on federal technological interest and utilization. It analyzes contract metadata, provided in a collaborative project with Govini, to track key emerging technologies through the federal procurement process.

Data Snapshots are informative descriptions and quick analyses that dig into CSET’s unique data resources. This five-part series uses data from the U.S. Department of Education and other select sources to complement existing CSET work on the U.S. AI workforce.

Vaccines keep the U.S. public healthy while safeguarding economic stability and biosecurity. This report assesses the domestic vaccine manufacturing landscape and identifies two major vulnerabilities: a reliance on foreign manufacturers and a lack of manufacturing redundancy. Maintaining a resilient vaccine supply will require the U.S. government to take steps to protect the existing supply, identify and monitor manufacturing vulnerabilities, and create a stronger domestic production base.

Pandemic threats are increasing as globalization, urbanization, and encroachment on animal habitats cause infectious outbreaks to become more frequent and severe. It is imperative that the United States build a pipeline of medical countermeasure development, beginning with basic scientific research and culminating in approved therapies. This report assesses preparedness for families of viral pathogens of pandemic potential and offers recommendations for steps the U.S. government can take to prepare for future pandemics.

CSET Research Analyst Dahlia Peterson testified before the U.S.-China Economic and Security Review Commission at a hearing on "China’s Challenges and Capabilities in Educating and Training the Next Generation Workforce."

CSET's Dr. Caroline Schuerger, Dr. Steph Batalis, and Vikram Venkatram submitted this comment with recommendations for the National Biotechnology and Biomanufacturing Initiative.

Translation Snapshots are short posts that highlight related translations produced by CSET’s in-house translation team. Each snapshot identifies relevant translations, provides short summaries, and links to full translations. Check back regularly for additional Translation Snapshots highlighting our work.

Biosafety Level-3 laboratories (BSL-3) are an essential part of research infrastructure and are used to develop vaccines and therapies. The research conducted in them provides insights into host-pathogen interactions that may help prevent future pandemics. However, these facilities also potentially pose a risk to society through lab accidents or misuse. Despite their importance, there is no comprehensive list of BSL-3 facilities, or the institutions in which they are housed. By systematically assessing PubMed articles published in English from 2006-2021, this paper maps institutions that host BSL-3 labs by their locations, augmenting current knowledge of where high-containment research is conducted globally.